Boehringer Ingelheim (BI) and Click Therapeutics have announced they are expanding their collaboration to develop and commercialise a second prescription-based digital therapeutic (PDT) that will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback